Literature DB >> 12628512

Molecular mechanism of the chemopreventive effect of resveratrol.

Zigang Dong1.   

Abstract

Chemoprevention is a promising approach to control human cancer. Resveratrol has been shown to have a potent chemopreventive effect in multiple carcinogenesis models. However, the precise mechanism explaining its anti-carcinogenic effect is not clear. This review summarizes recent studies from our laboratory on the mechanisms of resveratrol's effects. In JB6 cells, resveratrol was found to induce apoptosis and inhibit tumor promoter-induced cell transformation. We also found that resveratrol-induced activation of p53 and resveratrol-induced apoptosis occurred through a p53-dependent pathway. The MAP kinases, ERKs, JNKs, or p38 kinases, are involved in resveratrol-induced activation of p53 and apoptosis. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12628512     DOI: 10.1016/s0027-5107(02)00330-5

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  38 in total

1.  Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity.

Authors:  W D Johnson; R L Morrissey; A L Usborne; I Kapetanovic; J A Crowell; M Muzzio; D L McCormick
Journal:  Food Chem Toxicol       Date:  2011-09-10       Impact factor: 6.023

Review 2.  Grapevine as a Rich Source of Polyphenolic Compounds.

Authors:  Iva Šikuten; Petra Štambuk; Željko Andabaka; Ivana Tomaz; Zvjezdana Marković; Domagoj Stupić; Edi Maletić; Jasminka Karoglan Kontić; Darko Preiner
Journal:  Molecules       Date:  2020-11-28       Impact factor: 4.411

3.  Insulin-like growth factor II mediates resveratrol stimulatory effect on cathepsin D in breast cancer cells.

Authors:  Sharda Vyas; Yayesh Asmerom; Daisy D De León
Journal:  Growth Factors       Date:  2006-03       Impact factor: 2.511

4.  Oncogenicity evaluation of resveratrol in p53(+/-) (p53 knockout) mice.

Authors:  T L Horn; M J Cwik; R L Morrissey; I Kapetanovic; J A Crowell; T D Booth; D L McCormick
Journal:  Food Chem Toxicol       Date:  2006-08-08       Impact factor: 6.023

5.  Potential of resveratrol analogues as antagonists of osteoclasts and promoters of osteoblasts.

Authors:  Katarzyna Kupisiewicz; Patrice Boissy; Basem M Abdallah; Frederik Dagnaes Hansen; Reinhold G Erben; Jean-Francois Savouret; Kent Søe; Thomas L Andersen; Torben Plesner; Jean-Marie Delaisse
Journal:  Calcif Tissue Int       Date:  2010-09-15       Impact factor: 4.333

6.  Uptake of resveratrol and role of resveratrol-targeting protein, quinone reductase 2, in normally cultured human prostate cells.

Authors:  Tze-Chen Hsieh
Journal:  Asian J Androl       Date:  2009-09-21       Impact factor: 3.285

7.  Antitumor and immunomodulatory activity of resveratrol on experimentally implanted tumor of H22 in Balb/c mice.

Authors:  Hong-Shan Liu; Cheng-En Pan; Wei Yang; Xue-Min Liu
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

8.  The resveratrol analogue 3,5,3',4',5'-pentahydroxy-trans-stilbene inhibits cell transformation via MEK.

Authors:  Ki Won Lee; Nam Joo Kang; Evgeny A Rogozin; Sang-Muk Oh; Yong Seok Heo; Angelo Pugliese; Ann M Bode; Hyong Joo Lee; Zigang Dong
Journal:  Int J Cancer       Date:  2008-12-01       Impact factor: 7.396

9.  Differential effect of proIGF-II and IGF-II on resveratrol induced cell death by regulating survivin cellular localization and mitochondrial depolarization in breast cancer cells.

Authors:  S Kalla Singh; D Moretta; F Almaguel; N R Wall; M De León; D De León
Journal:  Growth Factors       Date:  2007-12       Impact factor: 2.511

10.  Immortalization of epithelial progenitor cells mediated by resveratrol.

Authors:  V P Pearce; J Sherrell; Z Lou; L Kopelovich; W E Wright; J W Shay
Journal:  Oncogene       Date:  2007-10-29       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.